INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
The CDK2 inhibitor INX-315 induces cell cycle arrest and therapy-induced senescence, thereby controlling the growth of CCNE1-amplified cancers and CDK4/6 inhibitor-resistant breast cancers, which...
aacrjournals.org